Publication:
Chitosan/poly(ethylene glycol)/hyaluronic acid biocompatible patches obtained by electrospraying

dc.contributor.authorsMutlu, Esra Cansever; Ficai, Anton; Ficai, Denisa; Yildirim, Arzu Birinci; Yildirim, Muhammet; Oktar, Faik Nuzhet; Demir, Arzu
dc.date.accessioned2022-03-12T22:27:10Z
dc.date.accessioned2026-01-11T10:25:06Z
dc.date.available2022-03-12T22:27:10Z
dc.date.issued2018
dc.description.abstractElectrospray is a promising technique to scale-up production of microparticles and nanoparticles. In this study, electrospraying was used in order to produce candidate biopatches (CPH) by using chitosan, poly (ethylene glycol) (PEG) and hyaluronic acid (HA). Four different ratios of polymer blend compositions (CPH1, CPH2, CPH3 and CPH4) were tested by dissolving in 2% acetic acid solution (Ac.A.). The HA amount in each blend was kept the same to designate the optimum surface with different chitosan/PEG ratios for electrospray process. Fourier-transform infrared (FTIR) microscopy, scanning electron microscopy (SEM), and atomic force microscopy (AFM) studies showed that obtained patches had highly adhesive surfaces with the aid of heterogeneously distributed micro- and nano-particles. Additionally, video images of FTIR microscopy and AFM images proved that all surfaces have similar heterogeneity except CPH2. The most homogenous surface was obtained by CPH3. Patches were directly subjected to antibacterial tests against ten different types of gram positive and gram negative bacteria using disc diffusion assay (Kirby-Bauer method). Extraordinarily there was no antibacterial property of patches coated with microparticles. Finally, biocompatibility studies were performed by using mouse fibroblast L929 cell lines (ATTC number CCL-1) to test cell adhesion and proliferation properties of the patches. Results of 72 h viability tests proved the electrospray of ternary blends had displayed good biocompatibility; in particular, CPH3 had the highest cell viability.
dc.identifier.doi10.1088/1748-605X/aad368
dc.identifier.eissn1748-605X
dc.identifier.issn1748-6041
dc.identifier.pubmed30004390
dc.identifier.urihttps://hdl.handle.net/11424/235167
dc.identifier.wosWOS:000440076800002
dc.language.isoeng
dc.publisherIOP PUBLISHING LTD
dc.relation.ispartofBIOMEDICAL MATERIALS
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectchitosan
dc.subjecthyaluronic acid
dc.subjectnanoparticle
dc.subjectbiocompatibility
dc.subjectelectrospray
dc.subjectpoly(ethylene glycol)
dc.subjectHYALURONIC-ACID
dc.subjectDRUG-DELIVERY
dc.subjectBLEND FILMS
dc.subjectNANOPARTICLES
dc.subjectMUCOADHESIVE
dc.subjectHYDROGEL
dc.subjectTHERAPY
dc.subjectRELEASE
dc.subjectIMPACT
dc.subjectCANCER
dc.titleChitosan/poly(ethylene glycol)/hyaluronic acid biocompatible patches obtained by electrospraying
dc.typearticle
dspace.entity.typePublication
oaire.citation.issue5
oaire.citation.titleBIOMEDICAL MATERIALS
oaire.citation.volume13

Files